We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $875B
1-Year Est. Return 40.91%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-13.42%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$390B
AUM Growth
-$94.7B
Cap. Flow
+$10.4B
Cap. Flow %
2.66%
Top 10 Hldgs %
28.21%
Holding
14,957
New
1,520
Increased
5,503
Reduced
5,522
Closed
2,191

Sector Composition

Rank Sector Weight
1 Healthcare 2.83%
2 Technology 2.79%
3 Financials 2.29%
4 Consumer Discretionary 1.93%
5 Industrials 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PHLT
11576
CALL
DELISTED
Performant Healthcare Inc
PHLT
$73K ﹤0.01%
27,700
+800
+3% +$1.99K
AKTS
11577
PUT
DELISTED
Akoustis Technologies Inc
AKTS
$73K ﹤0.01%
19,700
+3,700
+23% +$16.4K
MPRAW
11578
DELISTED
Mercato Partners Acquisition Corporation Warrant
MPRAW
$73K ﹤0.01%
764,348
-1,001
-0.1% -$243
FATH
11579
PUT
DELISTED
Fathom Digital Manufacturing Corporation
FATH
$73K ﹤0.01%
+940
New +$107K
USX
11580
CALL
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
$73K ﹤0.01%
27,300
-5,400
-17% -$16.8K
PLXP
11581
PUT
DELISTED
PLx Pharma Inc. Common Stock
PLXP
$73K ﹤0.01%
30,000
-18,800
-39% -$52.2K
DS
11582
PUT
DELISTED
Drive Shack Inc.
DS
$73K ﹤0.01%
53,300
-4,400
-8% -$6.27K
EOSE icon
11583
CALL
Eos Energy Enterprises
EOSE
$1.46B
$72K ﹤0.01%
59,800
+6,300
+12% +$12.9K
EVTL icon
11584
PUT
Vertical Aerospace
EVTL
$142M
$72K ﹤0.01%
2,290
-800
-26% -$48.1K
NEXA icon
11585
CALL
Nexa Resources
NEXA
$1.88B
$72K ﹤0.01%
11,900
-3,000
-20% -$25.5K
PMCB icon
11586
PharmaCyte Biotech
PMCB
$5.92M
$72K ﹤0.01%
+31,696
New +$69.3K
QRHC icon
11587
CALL
Quest Resource Holding
QRHC
$33.7M
$72K ﹤0.01%
17,700
+1,400
+9% +$7.01K
SNCR
11588
DELISTED
Synchronoss Technologies
SNCR
$72K ﹤0.01%
6,932
-2,189
-24% -$27.7K
EGLX
11589
CALL
DELISTED
Enthusiast Gaming Holdings Inc. Common Stock
EGLX
$72K ﹤0.01%
36,200
-30,800
-46% -$66.7K
AUID icon
11590
authID Inc
AUID
$8.83M
$71K ﹤0.01%
+4,593
New +$113K
BNED icon
11591
PUT
Barnes & Noble Education
BNED
$421M
$71K ﹤0.01%
+242
New +$70.2K
IGC icon
11592
CALL
IGC Pharma
IGC
$31.1M
$71K ﹤0.01%
133,200
+15,400
+13% +$9.71K
NGNE icon
11593
CALL
Neurogene
NGNE
$723M
$71K ﹤0.01%
3,445
-220
-6% -$5.37K
XERS icon
11594
PUT
Xeris Biopharma Holdings
XERS
$1.57B
$71K ﹤0.01%
46,300
+400
+0.9% +$844
BVC
11595
BitVentures Limited Ordinary Shares
BVC
$2.53B
$71K ﹤0.01%
+10,382
New +$71.8K
PHXM
11596
CALL
DELISTED
PHAXIAM Therapeutics S.A.. American Depositary Shares
PHXM
$71K ﹤0.01%
6,470
-22,590
-78% -$280K
KLR
11597
DELISTED
Kaleyra, Inc.
KLR
$71K ﹤0.01%
9,884
+2,435
+33% +$35.7K
EPZM
11598
PUT
DELISTED
Epizyme, Inc
EPZM
$71K ﹤0.01%
48,500
+22,400
+86% +$16.5K
MACK
11599
CALL
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$71K ﹤0.01%
+11,900
New +$67.1K
AEYE icon
11600
CALL
AudioEye
AEYE
$100M
$70K ﹤0.01%
+11,600
New +$54.5K

Similar funds

Citadel Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, Citadel Advisors held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Citadel Advisors's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.

By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.

  • Citadel Advisors's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
  • Citadel Advisors added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
  • Citadel Advisors's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
  • Citadel Advisors fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
  • Citadel Advisors's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
  • Citadel Advisors opened 1,520 new positions and closed 2,191 in Q2 2022.
  • Citadel Advisors's portfolio value fell 20% quarter-over-quarter to $390B.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.